Use of LC ‐ MS to characterize host cell protein removal during depth filtration
Biotechnology Progress · 2025
DOI: 10.1002/btpr.70044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Progress, 2025. Verfasst von Liang-Kai Chu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, The Pennsylvania State University, University Park, Pennsylvania, USA. Hauptthemen laut MEDLINE: Filtration, Mass Spectrometry, Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Bristol-Myers Squibb, Cancer Prevention Research Institute of Texas, Cancer Prevention and Research Institute of Texas.
Abstract (Originalsprache)
The removal of host cell proteins (HCPs) is crucial in biopharmaceutical production, as residual impurities can impact product safety and efficacy. While a number of studies have demonstrated that depth filtration can provide significant HCP removal, there is little information on its effectiveness in removing specific HCPs. This study examines the application of liquid chromatography‐mass spectrometry (LC‐MS) to track HCP removal during depth filtration, providing a detailed analysis of HCP behavior with two commercial depth filters. Our findings reveal significant variability in HCP breakthrough behavior, with transmission patterns showing minimal correlation with either the protein isoelectric point or hydrophobicity, highlighting the unique behavior of individual HCPs. Both the X0SP and X0HC depth filters achieved almost complete removal of Lipoprotein Lipase, and the X0SP filter also effectively removed Lysosomal Acid Lipase (LAL), both known to degrade polysorbate in monoclonal antibody formulations. However, neither filter provided significant removal of Alpha‐enolase, Carboxypeptidase D, Glutathione S‐transferase, or Phospholipase B‐like 2. The X0SP filter showed equal or better removal for 18 out of 20 problematic HCPs, with greater HCP removal seen at lower conductivity. This work provides a detailed framework for understanding and optimizing depth filtration processes, offering insights into the effectiveness of depth filters for removal of problematic HCPs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical Engineering, The Pennsylvania State University, University Park, Pennsylvania, USA.
- Bristol Myers Squibb, Biologics Development, Global Product Development and Supply, Devens, Massachusetts, USA.
ORCID-Profile: Andrew L Zydney
Förderung
- Bristol-Myers Squibb
- Cancer Prevention Research Institute of Texas
- Cancer Prevention and Research Institute of Texas
Zitieren
APA
Chu, L. K., Borujeni, E. E., Xu, X., & Zydney, A. L. (2025). Use of LC ‐ MS to characterize host cell protein removal during depth filtration. Biotechnology Progress. https://doi.org/10.1002/btpr.70044
Vancouver
Chu LK, Borujeni EE, Xu X, Zydney AL. Use of LC ‐ MS to characterize host cell protein removal during depth filtration. Biotechnology Progress. 2025. doi:10.1002/btpr.70044
BibTeX
@article{Chu2025,
author = {Chu, Liang-Kai and Borujeni, Ehsan Espah and Xu, Xuankuo and Zydney, Andrew L},
title = {Use of LC ‐ MS to characterize host cell protein removal during depth filtration},
journal = {Biotechnology Progress},
year = {2025},
doi = {10.1002/btpr.70044}
}
EUVIMED